Adherence after 6 months
| Adherence variables | Total | First csDMARD | Second-line csDMARD | bDMARD/tsDMARD |
| Prevalence* (%) (95% CI) | 59.1 (48.1 to 71.8) | 43.1 (27.9 to 63.6) | 70.4 (49.8 to 96.6) | 64.4 (45.6 to 88.4) |
| CQR score, mean±SD | 86.0±9.4 | 83.6±9.3 | 87.2±9.2 | 86.0±9.4 |
| RAM score, mean±SD | 80.6±25.8 | 80.6±22.9 | 80.5±27.9 | 80.9±26.9 |
*Defined as a score above 80% in the CQR and RAM scales.
bDMARD, biological disease-modifying antirheumatic drug; CQR, Compliance Questionnaire Rheumatology; csDMARD, conventional synthetic disease-modifying antirheumatic drug; RAM, Reported Adherence to Medication; tsDMARD, targeted synthetic disease-modifying antirheumatic drug.